Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Reviews: Research and development for novel anti-cancer drugs: to meet unmet medical needs
Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT® technology
Toshihiko Ishii
Author information
JOURNAL FREE ACCESS

2013 Volume 142 Issue 4 Pages 167-171

Details
Download PDF (863K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
[in Japanese]
Content from these authors
© 2013 by The Japanese Pharmacological Society
Previous article Next article
Favorites & Alerts

Recently viewed articles
Predecessor

Nippon Yakubutsugaku Zasshi (Folia Pharmacologica Japonica)

Share this page
feedback
 Top